Selected article for: "abundant protein and acute sars respiratory syndrome"
Author: Djukic, Teodora; Mladenovic, Maja; Stanic-Vucinic, Dragana; Radosavljevic, Jelena; Smiljanic, Katarina; Sabljic, Ljiljana; Devic, Marija; Cujic, Danica; Vasovic, Tamara; Simovic, Ana; Radomirovic, Mirjana; Cirkovic Velickovic, Tanja
Title: Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2
  • Cord-id: 3a09lcvo
  • Document date: 2021_2_9
    • ID: 3a09lcvo
    Snippet: Serological testing is important method for diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nucleocapsid (N) protein is the most abundant virus derived protein and strong immunogen. We aimed to find its efficient, low-cost production. SARS-CoV-2 recombinant fragment of nucleocapsid protein (rfNP; 58–419 aa) was expressed in E. coli in soluble form, purified and characterized biochemically and immunologically. Purified rfNP has secondary structure of full-le
    Document: Serological testing is important method for diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nucleocapsid (N) protein is the most abundant virus derived protein and strong immunogen. We aimed to find its efficient, low-cost production. SARS-CoV-2 recombinant fragment of nucleocapsid protein (rfNP; 58–419 aa) was expressed in E. coli in soluble form, purified and characterized biochemically and immunologically. Purified rfNP has secondary structure of full-length recombinant N protein, with high percentage of disordered structure (34.2%) and of β-sheet (40.7%). rfNP was tested in immunoblot using sera of COVID-19 convalescent patients. ELISA was optimized with sera of RT-PCR confirmed positive symptomatic patients and healthy individuals. IgG detection sensitivity was 96% (47/50) and specificity 97% (67/68), while IgM detection was slightly lower (94% and 96.5%, respectively). Cost-effective approach for soluble recombinant N protein fragment production was developed, with reliable IgG and IgM antibodies detection of SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • absence presence and low binding: 1
    • absence presence and low igm sensitivity: 1, 2
    • absence presence and low sensitivity: 1, 2, 3, 4, 5, 6, 7
    • absence presence and low specificity: 1, 2
    • abundant virus and acute disease: 1
    • abundant virus and low sensitivity: 1, 2
    • acute disease and additional protein: 1, 2, 3, 4
    • acute disease and additional purification: 1
    • acute disease and low binding: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute disease and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute disease and low specificity: 1, 2, 3, 4, 5, 6